Montaser Shaheen, MD, Hematology & Oncology, The UT Health San Antonio Mays Cancer Center, was interviewed for this news segment about the results of a phase II clinical trial showing participants with stage III and IV melanoma who received treatment before and after surgery, had significantly lower risks of cancer.